Central Retinal Vein Occlusion

Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications

A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products

601 Versus Ranibizumab in Patients With Central Retinal Vein Occlusion (CRVO)

Spontaneous Retinal Artery Pulses (SPARs) as a Prognostic Determinant of Central Retinal Vein Occlusions (CRVO) in Patients With or Without Intravitreal Aflibercept Injections

Treatment of Central Retinal Vein Occlusion Using Stem Cells Study

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion

Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVO

Surgical Stabilizer Assisted RVC With rtPA for CRVO

Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion

A Pilot Study of Functional Optical Coherence Tomography for Ocular Imaging

Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study

Conbercept Ophthalmic Injection for Patients of Central Retinal Vein Occlusion

Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2)

Peripheral and Macular Retinal Vascular Perfusion and Leakage in DME and RVO

Comparing Injection Frequency Between Aflibercept and Ranibizumab in Patients With CRVO With a Treat& Extend Regimen

Central Retinal Vein Occlusion (CRVO) Treatment With Bevacizumab and Dexamethasone or Bevacizumab Only.

Evaluation of a Treat and Extend Regimen of Intravitreal Aflibercept for Macular Edema Secondary to CRVO

Retrospective Study of the Effectiveness and Safety of Niacin and Steroid Eye Drops for Retinal Vein Occlusions

Intra-arterial Thrombolysis for Severe Recent Central Retinal Vein Occlusion

Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO)